{
  "abstract": "Imaging mass cytometry (IMC) is a multiplex imaging platform allowing for the simultaneous visualisation of up to 40 different protein targets enabling in-depth studies of tissue histology within their spatial context. We have applied IMC to examine a range of kidney pathologies, including inflammation in kidney allografts, 1 immune checkpoint inhibitor-associated interstitial nephritis2 and kidney disease related to COVID-19.3",
  "authors": [
    {
      "affiliations": [
        "Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA"
      ],
      "name": "Mariam Priya Alexander"
    },
    {
      "affiliations": [
        "Immune Monitoring Core, Mayo Clinic Minnesota, Rochester, Minnesota, USA"
      ],
      "name": "Kevin Pavelko"
    },
    {
      "affiliations": [
        "Immune Monitoring Core, Mayo Clinic Minnesota, Rochester, Minnesota, USA"
      ],
      "name": "Michael Strausbauch"
    },
    {
      "affiliations": [
        "Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA"
      ],
      "name": "Vidhya Dharshini Murugesan"
    },
    {
      "affiliations": [
        "Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA"
      ],
      "name": "Taxiarchis Kourelis"
    },
    {
      "affiliations": [
        "Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada"
      ],
      "name": "Trevor Mckee"
    },
    {
      "affiliations": [
        "Department of Surgery, and Department of Immunology, Mayo Clinic, Rochester, Minnesota, USA"
      ],
      "name": "Timucin Taner"
    }
  ],
  "title": "Fixative faux pas: glutaraldehyde’s limitation in imaging mass cytometry studies of kidney biopsies",
  "uid": "2f974251-5102-5f08-b33d-41ccf67c44dd"
}